Veterinary Medicine Spectinomycin Hydrochloride Powder CAS 21736-83-4 Raw Materials
Veterinary Medicine Spectinomycin Hydrochloride Powder CAS 21736-83-4 Raw Materials
factory
certificate
Home > Antiviral drugs

Veterinary Medicine Spectinomycin Hydrochloride Powder CAS 21736-83-4 Raw Materials

Related Attributes


Product details

Spectinomycin Hydrochloride Powder Usage and Synthesis.

Spectinomycin Hydrochloride is produced by Streptomyces sp. Spectinomycin Hydrochloride Powder is an aminoglycoside fast-acting bactericidal-antimicrobial agent consisting of a glycosidic bond between a neutral sugar and an aminocyclic alcohol. Spectinomycin Hydrochloride Powder is an aminoglycoside fast-acting bactericidal antimicrobial agent consisting of a glycosidic bond between a neutral sugar and an aminocyclic alcohol.

Spectinomycin Hydrochloride Raw MaterialsIn livestock and poultry veterinary therapeutic clinics, Spectinomycin Hydrochloride is mainly used for the treatment of diseases caused by Escherichia coli. the treatment of diseases caused by Escherichia coli, Salmonella, Bartonella and Mycoplasma caused by sensitive bacterial infections.

Spectinomycin Hydrochloride Powder

Spectinomycin Hydrochloride Powder is used for the treatment of G-bacteria, Mycoplasma and co-infections of Mycoplasma and bacteria. It is mainly used to prevent and control the infection of Escherichia coli, Salmonella, Bartonella and Mycoplasma caused by sensitive bacterial infections. It is mainly used to prevent and control the infection of Escherichia coli, Salmonella, Bartonella and Mycoplasma in piglets.

Uses and functions of Spectinomycin Hydrochloride Powder.

Spectinomycin Hydrochloride belongs to broad-spectrum and rapid bactericides, it has strong effects on Escherichia coli, Salmonella, Bartonella, Proteus, hemolytic streptococcus, Streptococcus pneumoniae and Pneumococcus pneumoniae, etc.; therefore, it has a better clinical therapeutic effect for the treatment of infectious diseases caused by the above sensitive bacteria.

Spectinomycin Hydrochloride Powder

It has inhibitory effect on Gram-positive and negative bacteria. It has strong antibacterial effect on gonococcus, and also has good antibacterial activity on gonococcus that produces B-lactamase, which is a new type of special-effective drug for the treatment of gonorrhea.

Indications for the treatment of G-bacteria, mycoplasma and mycoplasma and bacterial co-infection. It is mainly used for the prevention and treatment of E. coli, Salmonella, Pasteurella and Mycoplasma infections in piglets.

Pharmacological Effects of Spectinomycin Hydrochloride Powder.

Spectinomycin belongs to alkaline antimicrobial agent, the stronger the alkaline the stronger the antimicrobial potency; however, Spectinomycin is not soluble in water, so the most commonly used commercialized original drug in China is Spectinomycin Hydrochloride.

It is white or off-white crystalline powder under quality assurance standard;

Spectinomycin Hydrochloride Powder

It is easily soluble in water, the aqueous solution dissolved in water shows acidic test results, and the pH of its 1% aqueous solution is 3.8-5.6. It is insoluble in organic solvents such as methanol, ethanol and propylene glycol. It is mainly used for the treatment of urethritis, cervicitis, proctitis and acute gonorrhea caused by gonococcus.

Production method of Spectinomycin Hydrochloride Powder.

The antibacterial mechanism of Spectinomycin Hydrochloride is the same as that of other aminoglycoside antibacterial agents, which is to enter into the bacterial cell and selectively act on the 30s subunit of the bacterial cell nuclear proteasome, so as to produce strong inhibition of bacterial cell protein synthesis, and to produce strong killing effect on sensitive bacteria.


Why choose us?

factory

HRK Factory

HRK Factory

About Shipping

shipping

Prev: Marbofloxacin CAS 115550-35-1 Raw Materials Powder Next: Veterinary Medicine Pefloxacin Mesylate Powder CAS 70458-95-6 Raw Materials

Pharmaceutical Intermediate manufacturers

sales18@interlgroup.com

©2022 Xi'an Henrikang Biotech Co., Ltd.,

HomeHome
EmailE-mail
ProductBooking